Ho-Ho-Kus, NJ, United States of America

Kenneth Malley


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kenneth Malley: Innovator in Generic Opportunity Scoring

Introduction

Kenneth Malley is a notable inventor based in Ho-Ho-Kus, NJ (US). He has made significant contributions to the field of healthcare through his innovative patent related to generic drug utilization. His work aims to enhance the identification and improvement of generic opportunities in the pharmaceutical industry.

Latest Patents

Kenneth Malley holds a patent for "Methods and systems for generic opportunity scoring." This computer-implemented method determines a Generic Opportunity Score (GOS) that demonstrates how generic utilization can be better identified and improved. The GOS provides savings information relative to clinically appropriate generic alternatives. The process calculates the GOS as the proportion of generic prescriptions dispensed compared to the maximum number of prescriptions that have a generic equivalent. Additionally, it can determine the GOS based on the number of generic claims dispensed over the total number of generic claims plus brand claims that have a generic equivalent.

Career Highlights

Kenneth Malley is associated with Medcohealth Solutions, Inc., where he applies his expertise in developing systems that enhance generic drug performance. His innovative approach has the potential to significantly impact healthcare savings and improve patient access to affordable medications.

Collaborations

Throughout his career, Kenneth has collaborated with notable colleagues such as Karnik Patel and Keith Bradbury. These partnerships have contributed to the advancement of his work in the field of generic drug utilization.

Conclusion

Kenneth Malley's contributions to the field of generic opportunity scoring exemplify the importance of innovation in healthcare. His patent and collaborative efforts aim to improve the efficiency of generic drug utilization, ultimately benefiting both healthcare providers and patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…